Contract Manufacturing, General

CDMO, Vibalogics, has revealed that it will be acquired by a private equity firm, Ampersand Capital Partners.

The company announced plans to construct a 1.3 million-ft2 integrated manufacturing center in Chengdu, China.

The expansion of the CDMO’s Skokie, IL facility includes additional refrigeration and freezer space.

Contract manufacturing organizations need to adapt to successfully overcome the specific challenges posed by complex therapies.

Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium.

A $100-million investment will expand a range of the CDMO’s service capabilities and offerings.

Technology vendors are strengthening their positions in China as the nation emphasizes self-sufficiency in research, development, and manufacturing.

The company is set to expand biologics and fill/finish capacity at its biologics manufacturing sites in Madison, WI, and Bloomington, IN.

The partnership provides Sarepta with capacity and manufacturing slots for GMP-grade plasmid production for its micro-dystrophin Duchenne muscular dystrophy gene therapy program, as well as plasmid capacity for future gene therapy programs.

The Massachusetts site, formerly associated with an affiliate of Shire, is Rentschler Biopharma’s first facility in the US.

The company has brought a second stream of high-throughput GMP peptide manufacturing online.

CMOs and CDMOs made investments in new and expanded facilities and services in the last quarter of 2018.

The contract development and manufacturing organization released its first serialized products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.

According to CPhI’s annual report, the therapeutic antibody drug conjugates (ADC) market is expected to reach $4 billion by 2023.

The new facility will include comprehensive mammalian process development and manufacturing capabilities.

Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.

While food, shelter, and clothing are the primal essentials for life, hope-as embodied by modern medicine-has now become part of that human expectation.

The contract development and manufacturing organization expanded its analytical chemistry suite and added a new office in Boston, MA.

Avara Pharmaceutical Services acquired Sandoz’s sterile manufacturing facility for injectable medicines in Boucherville, Quebec, Canada.

More than 120 healthcare organizations plan to bring competition to generic drug market.

The company is certified as a manufacturer of pressure vessels and components for use in China.

The acquisition is expected to support Emergent BioSolutions’ focus on public health threats and emerging infectious disease.

The API and drug product provider will invest £375,000 (US$493,000) in additional nuclear magnetic resonance (NMR) instrumentation at its headquarters in Craigavon, UK.

This article highlights 15 years of changes in biopharmaceutical manufacturing.

TxCell announces manufacturing agreement with Lonza for its HLA-A2 CAR-Treg cellular product.